Navigation Links
Xmark Comments on Genaera Cost-Saving Plan
Date:5/9/2008

RIDGEFIELD, Conn., May 9 /PRNewswire/ -- Xmark Opportunity Partners, LLC, the investment manager to Xmark Opportunity Fund, L.P., Xmark Opportunity Fund, Ltd. and Xmark JV Investment Partners, LLC, announced today that it fully supports the initiatives outlined in the press release issued by Genaera Corporation (Nasdaq: GENR) on May 8, 2008 with respect to executive base compensation, cash incentives to executives, workforce reduction and the streamlining of expenditures.

"Management has made difficult, fiscally-responsible choices that will afford its shareholders the opportunity to profit from MSI-1436 and MEDI-528 without suffering dilution during a turbulent period in the markets," said Mitchell D. Kaye, the Chief Executive Officer of Xmark Opportunity Partners. Mr. Kaye added that, "this type of responsible behavior should serve as a model for similarly-situated companies in the small-cap biotech sector." Mr. Kaye is a member of the Board of Directors of Genaera.


'/>"/>
SOURCE Xmark Opportunity Partners, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
2. FRC Action Praises John McCains Pro-Life Comments
3. JAMA editor-in-chief comments on Pfizer lawsuit
4. Vital Images Comments on CMS Decision to Allow Local Coverage for Cardiac CT Angiography
5. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
6. MGT Comments on American Cancer Societys Decision to Endorse CT Colonography
7. URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards
8. American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications
9. Boston Scientific Comments on New England Journal of Medicine Article
10. URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs
11. American College of Surgeons Comments on JAMA Article on Surgeon Shortage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...consumers on indoor air quality, ANN ARBOR, Mich....onth,according the Environmental Protection Agency...ng this opportunity to educate consumers on the,im...erious condition. The,EPA states that asthma sent ...n the year 2000, and according to the American Lun...
(Date:5/12/2008)...ors, there exists among the multitude of warrior c... patiently lying in wait to launch their attacks. ...leukemia initiating cells (LICs), these stealth po...apy and undaunted by targeted cancer therapies. Wh...of remission, it is the LICs that bear responsibil...
(Date:5/12/2008)...f-life care for older people in the final stages o...ublished in the May issue of Journal of Clinical N...ementia from suffering from protracted, potentiall...aper, Professor of Nursing for The Open University...a major international public health concern becaus...
(Date:5/12/2008)...Ruth Kluck at Melbournes Walter and Eliza Hall Ins...hanism by which cells destroy themselves. In this ...the cell to self-destruct by puncturing its power ... by the WEHI team. The discovery is an important s...s designed to regulate cell death. , Dr Kluck a...
Breaking Medicine News(10 mins):Health News:Asthma Awareness Month Spawns Healthy Advice 2Health News:Arsenic-based therapy shown to help eradicate leukemia-initiating cells 2Health News:Arsenic-based therapy shown to help eradicate leukemia-initiating cells 3Health News:End-stage dementia patients deserve the same access to palliative care as people with cancer 2Health News:End-stage dementia patients deserve the same access to palliative care as people with cancer 3Health News:Key step in the 'puncture' mechanism of cell death revealed 2
...cular diseases for better in as early as eight wee...ference on Arteriosclerosis, Thrombosis and Vascul...se regimen with Mediterranean type diet may bring ...tion and effectiveness for people who have a high ...
...vily to high blood pressure and cardiovascular dis...can happen through transcendental meditation progr...se diseases. For population over 55 years of age, ...ife, interventions in the form of meditation may h...
...on of Clopidogrel and aspirin is more effective th... 107 participants across four countries of the Eur...aspirin. Each of the participants of the study had...attack (TIA). All the patients have at least 50% n...
...a common procedure. A new research says that influ...gnant mothers as a precautionary measure. Influenz...e containing killed virus that is injected into th... older than 6 months, including people with chroni...
Other Medicine News:
(Date:5/8/2008)...search Alliance, an,organization comprised of 12 o...illion Americans to exercise their power over canc...Mother,s Day through Father,s Day., The campaign,...y goals:,to activate Americans everywhere to take ...o exercise their collective power over cancer, and...
(Date:5/8/2008)...herapeutic Proteins at Tumor,Site, ARLINGTON HE...g gene,therapy, plastic surgeons have delivered ca...n cancerous tumors on rats with a 79 percent reduc...May issue of Plastic and,Reconstructive Surgery(R)...iety of Plastic Surgeons (ASPS). This new delivery...
(Date:5/8/2008)...ll/ -- AstraZeneca (NYSE:,AZN) today announced the...,(sNDA) to the U.S. Food and Drug Administration (...ended-Release Tablets to seek approval for the,tre...uding maintenance of,antianxiety effect. It is the...al antipsychotic medicine in GAD. The submission i...
(Date:5/7/2008)...Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) annou...itiated a Phase 1 clinical trial of a drug candida...develop compounds to treat psychiatric disorders.,...ed for the treatment of a,common psychiatric disor... partner, Taisho,effectively continue its efforts...
Breaking Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 3Memory tasks require more coordinated brain blood flow for people with high blood pressure 2262 1Memory tasks require more coordinated brain blood flow for people with high blood pressure 2262 2Memory tasks require more coordinated brain blood flow for people with high blood pressure 2262 3HortTalks a valuable scientific resource 598 1HortTalks a valuable scientific resource 598 2Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1 2008 2259 1Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1 2008 2259 2Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program 2255 1Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program 2255 2
...e nanomedicine company,focused on the development ...rgeted therapies today presented a poster,abstract... (ASCO),Annual meeting. The poster, entitled "Prel...-6901," announced the preliminary data,of a Nation...es,sponsored Phase 1 trial of CYT-6091 (Aurimune),...
...ine provide support for,epigenetic and combination...use of Thalidomide to treat multiple myeloma, BOUL... Pharmion,Corporation reported today that data fro...y,s marketed and pipeline products will be,present...l,Oncology,s (ASCO) 43rd Annual Meeting in Chicago...
Other Medicine Technology:CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 2CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 3Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 2Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 3Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 4Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 5Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 6Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 7
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
CUSA DISSECTRON PORTABLE UNIT is an ultrasonic surgical aspirator for the fragmentation and emulsification of tissue available only outside the United States.
Medicine Products: